Systemic amyloidosis of beta 2 microglobulin type.
AUTOR(ES)
Mazanec, K
RESUMO
A patient receiving haemodialysis for 15 years developed systemic amyloidosis of beta 2 microglobulin type. Noticeable deposits of amyloid were present in the myocardium, intervertebral discs, joint cartilages and tendons. Less conspicuous amounts were present in blood vessel walls in the lungs, liver, adrenal glands and brain, and within the stroma of the prostate, testis and kidney, often with foci of calcification.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=495119Documentos Relacionados
- Beta 2 microglobulin haemodialysis related amyloidosis: distinctive gross features of gastrointestinal involvement.
- Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.
- Pseudotumoral amyloidosis of beta 2-microglobulin origin in the buttock of a patient receiving long term haemodialysis.
- Importance of beta2-microglobulin in murine resistance to mucosal and systemic candidiasis.
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.